ALL
-
-
Dec 09, 2022 product/service
-
-
product/service
-
Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(125 KB)
-
-
Nov 22, 2022 stock
-
-
stock
-
Notice of Acquisition Result of Company Stock Through Off-Floor Trading (ToSTNeT-3) for Purchase of Company Stock and Completion of Acquisition of Company Stock(153 KB)
-
-
Nov 21, 2022 stock
-
-
stock
-
Notice of Acquisition of Company Stock and Purchase of Company Stock Through Off-Floor Trading (ToSTNeT-3) for Purchase of Company Stock(168 KB)
-
-
Nov 11, 2022 performance
-
-
performance
-
Consolidated Financial Results for the Six Months Ended September 30, 2022(504 KB)
-
-
Nov 07, 2022 performance
-
-
performance
-
Notice Regarding Revision of the Earnings Forecasts for the First Half of Fiscal Year Ending March 2023(120 KB)
-
-
Oct 25, 2022 other
-
-
other
-
Notice Regarding Contract on Distribution Operation of Dovonex®Ointment50μg/g, a Topical Treatment of Psoriasis Vulgaris by LEO Pharma K.K.(163 KB)
-
-
Sep 08, 2022 product/service
-
-
product/service
-
TOHO PHARMACEUTICAL and Sysmex to Commence Dry Ice-free Supply of Quality Control Reagents for Clinical Chemistry Tests – Realizing a Sustainable Cold Chain –(340 KB)
-
-
Aug 15, 2022 product/service
-
-
product/service
-
Notice Regarding Marketing Approvals for 1 Ingredient / 2 Product of Generic Drugs for KYOSOMIRAI PHARMA(173 KB)
-
-
Aug 05, 2022 performance
-
-
performance
-
Consolidated Financial Results for the Three Months Ended June 30, 2022(389 KB)
-
-
Jul 06, 2022 product/service
-
-
product/service
-
To Deliver Specialty Pharmaceuticals Safely and Securely
Notice Regarding a New Constant-Temperature Transportation Device “SALM FZ” which Provides a Rigorous Temperature Control in a Wide Range of Temperature(121 KB)
-
-
Jun 29, 2022 corporate
-
-
corporate
-
Notice Regarding Change of Representative Directors(75 KB)
-
-
Jun 29, 2022 corporate
-
-
corporate
-
Notice Regarding Executive Appointment(121 KB)
-
-
Jun 17, 2022 product/service
-
-
product/service
-
Notice Regarding Launch of 2 Ingredients / 3 Products of Generic Drugs for KYOSOMIRAI PHARMA(122 KB)
-
-
Jun 15, 2022 product/service
-
-
product/service
-
Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of Imatinib Tablets 100mg “KMP” for KYOSOMIRAI PHARMA(153 KB)
